Glauspec 20 mg, 5 mg Ophthalmic Solution
PDF Leaflet Revision Date: 28 March 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of elevated intra-ocular pressure in glaucoma.
Dosage (summary)
One drop in affected eye(s) twice daily.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not established for safety in pregnancy; avoid during lactation.
Key Drug Interactions
- Calcium channel blockers
- Beta-adrenergic blocking agents
- Oral carbonic anhydrase inhibitors
Contraindications
- Hypersensitivity to components
- Reactive airway disease
- Severe renal impairment
- Severe cardiac conditions
Common side effects
- Burning and stinging
- Blurred vision
- Taste perversion
- Headache
Counselling Points
- Do not wear contact lenses during use
- Monitor for respiratory symptoms
- Avoid abrupt discontinuation if on beta-blockers
Serious warnings
- Caution in patients with respiratory disorders
- Potential for systemic effects due to beta-blockade
Important Disclaimer
The Glauspec 20 mg, 5 mg Ophthalmic Solution professional information leaflet below is the property of Trinity Pharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
